Oct
2026
Fiera Milano, Italy
Visit us
stand 3F1, API
FARMAK, a.s.
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:Czech Republic
-
On CPHI since:2015
-
Certificates:4
-
Employees:250 - 499
Company types
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 3F1, API
Products Featured at CPHI Milan 2026
-
Product Brimonidin Tartrate
Therapeutic group: Antiglaucoma; symptotic treatment of rosacea -
Product Bromfenac Sodium (Sesquihydrate)
Therapeutic group: Anti-inflammatory (ophthalmic) -
Product Alfuzosin hydrochloride (CEP grade)
FARMAK manufactures Alfuzosin hydrochloride. It belongs to active ingredients (API) products category. We offer CEP granted by EDQM.
Contact us for more information. -
Product Brimonidine tartrate (CEP grade)
FARMAK manufactures Brimonidine tartrate. It belongs to active ingredients (API) products category. We offer CEP granted by EDQM.
Contact us for more information. -
Product Butamirate citrate
FARMAK manufactures Butamirate citrate. It belongs to active ingredients (API) products category. Contact us for more information.
FARMAK, a.s. Resources (1)
-
Brochure FARMAK Presentation
FARMAK Presentation 2020




